Doctors test 'Evolutionary' timing strategies in fight against rare childhood cancer

NCT ID NCT04388839

Ongoing Disease control Sponsor: H. Lee Moffitt Cancer Center and Research Institute Source: ClinicalTrials.gov ↗

Summary

This study is testing whether changing the timing of chemotherapy can help control metastatic rhabdomyosarcoma, a rare and aggressive childhood cancer. Participants and their doctors choose between four different chemotherapy schedule strategies to see which approach works best. The trial involves 12 newly diagnosed patients with a specific genetic type of the cancer that has spread to other parts of the body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Carolinas Medical Center, Levine Cancer Institute

Charlotte, North Carolina, 28204, United States
Children's Hospital of Colorado

Aurora, Colorado, 80045, United States
Cleveland Clinic

Cleveland, Ohio, 44106, United States
Connecticut Children's Medical Center

Hartford, Connecticut, 06106, United States
Duke Children's Hospital

Durham, North Carolina, 27710, United States
Johns Hopkins All Children's Hospital

St. Petersburg, Florida, 33701, United States
MD Anderson

Houston, Texas, 77030, United States
Moffitt Cancer Center

Tampa, Florida, 33612, United States
Montefiore Medical Cancer Center

The Bronx, New York, 10467, United States
Nationwide Children's Hospital

Columbus, Ohio, 43205, United States
Primary Children's Medical Center/Utah

Salt Lake City, Utah, 84113, United States
Roswell Park Comprehensive Cancer Center

Buffalo, New York, 14263, United States
University of Alabama at Birmingham Comprehensive Cancer Center

Birmingham, Alabama, 35294, United States
University of Florida

Gainesville, Florida, 32610, United States
University of Miami - Sylvester Comprehensive Cancer Center

Miami, Florida, 33136, United States
University of North Carolina Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, 27599, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States
Vanderbilt - Ingram Cancer Center

Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.

RHABDOMYOSARCOMA